RIFAXIMIN IS EFFICACIOUS FOR THE TREATMENT OF IRRITABLE BOWEL SYNDROME WITH DIARRHEA (IBS-D) IN ADULTS PREVIOUSLY TREATED WITH OTHER IBS MEDICATIONS

被引：0
作者：
Rao, Satish S.
Schoenfeld, Philip S.
Heimanson, Zeev
Rezaie, Ali
Lacy, Brian E.
机构：
来源：
GASTROENTEROLOGY | 2020年 / 158卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Mo1329
引用
收藏
页码：S852 / S852
页数：1
相关论文
共 50 条
  • [31] Characterizing Diarrhea in Irritable Bowel Syndrome (IBS)
    Palsson, Olafur S.
    Turner, Marsha J.
    Baggish, Jeffrey S.
    Whitehead, William E.
    GASTROENTEROLOGY, 2009, 136 (05) : A376 - A376
  • [32] Irritable bowel syndrome with diarrhea (IBS-D) treated with moxibustion on heat-sensitive acupoints: a randomized controlled trial
    Hu Dan
    Kang Ming-fei
    Xiong Jun
    Deng Peng
    WORLD JOURNAL OF ACUPUNCTURE-MOXIBUSTION, 2012, 22 (02) : 1 - 5
  • [33] AGA Clinical Practice Guidelines on the Laboratory Evaluation of Functional Diarrhea and Diarrhea-Predominant Irritable Bowel Syndrome in Adults (IBS-D)
    Smalley, Walter
    Falck-Ytter, Corinna
    Carrasco-Labra, Alonso
    Wani, Sachin
    Lytvyn, Lyubov
    Falck-Ytter, Yngve
    GASTROENTEROLOGY, 2019, 157 (03) : 851 - 854
  • [34] Rifaximin for Improving Abdominal Pain and Bloating Symptoms in Patients With Irritable Bowel Syndrome With Diarrhea (IBS-D) Using Modified Definitions of Pain Response
    Lacy, Brian E.
    Heimanson, Zeev
    Pimentel, Mark
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2018, 113 : S263 - S263
  • [35] RIFAXIMIN FOR IMPROVING ABDOMINAL PAIN AND BLOATING SYMPTOMS IN PATIENTS WITH IRRITABLE BOWEL SYNDROME WITH DIARRHEA (IBS-D) USING MODIFIED DEFINITIONS OF PAIN RESPONSE
    Lacy, Brian E.
    Heimanson, Zeev
    Pimentel, Mark
    GASTROENTEROLOGY, 2019, 156 (06) : S92 - S93
  • [36] Getting the BS out of Irritable Bowel Syndrome with Diarrhea (IBS-D): Let’s Make a Diagnosis
    Frissora C.L.
    Schiller L.R.
    Current Gastroenterology Reports, 2024, 26 (1) : 20 - 29
  • [37] Rifaximin for improving abdominal pain and bloating symptoms in patients with irritable bowel syndrome with diarrhea (IBS-D) using modified definitions of pain response
    Lacy, B.
    Heimanson, Z.
    Pimente, M.
    NEUROGASTROENTEROLOGY AND MOTILITY, 2019, 31
  • [38] Treatment-free interval (TFI): A novel approach to assessing real-world treatment response among patients with irritable Bowel syndrome with diarrhea (IBS-D) treated with rifaximin or eluxadoline
    Lacy, B. E.
    Gagnon-Sanschagrin, P.
    Heimanson, Z.
    Bungay, R.
    Bellefleur, R.
    Guerin, A.
    Dashputre, A.
    Bumpass, B.
    Borroto, D.
    Joseph, G.
    NEUROGASTROENTEROLOGY AND MOTILITY, 2023, 35
  • [39] Efficacy of Rifaximin on Bowel Movement Urgency in Patients with Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D): A Pooled Analysis of 3 Phase 3 Trials
    Pimentel, Mark
    Cash, Brooks D.
    Wolf, Ray
    Lembo, Anthony J.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2016, 111 : S253 - S254
  • [40] POTENTIAL FOR COST SAVINGS ASSOCIATED WITH A NOVEL IBS BLOOD PANEL FOR DIAGNOSING DIARRHEA PREDOMINANT IRRITABLE BOWEL SYNDROME (IBS-D): ITALIAN PERSPECTIVE
    Gabbani, T.
    Violanti, C.
    Deiana, S.
    Pimentel, M.
    Purdy, C.
    Magar, R.
    VALUE IN HEALTH, 2015, 18 (07) : A349 - A350
12345